These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1424176)

  • 1. The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women.
    Rushton DH; Ramsay ID
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):421-7. PubMed ID: 1424176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced serum vitamin B12 levels during oral cyproterone-acetate and ethinyl-oestradiol therapy in women with diffuse androgen-dependent alopecia.
    Ramsay ID; Rushton DH
    Clin Exp Dermatol; 1990 Jul; 15(4):277-81. PubMed ID: 2145099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
    Vexiau P; Chaspoux C; Boudou P; Fiet J; Jouanique C; Hardy N; Reygagne P
    Br J Dermatol; 2002 Jun; 146(6):992-9. PubMed ID: 12072067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproterone acetate for severe hirsutism: results of a double-blind dose-ranging study.
    Barth JH; Cherry CA; Wojnarowska F; Dawber RP
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):5-10. PubMed ID: 1832346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
    Peereboom-Wynia JD; van der Willigen AH; van Joost T; Stolz E
    Acta Derm Venereol; 1989; 69(5):395-8. PubMed ID: 2572103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair growth and androgen responses in hirsute women treated with continuous cyproterone acetate and cyclical ethinyl oestradiol.
    Jones DB; Ibraham I; Edwards CR
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):497-501. PubMed ID: 2962412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
    Brzezińska-Wcisło L
    Wiad Lek; 2003; 56(3-4):202-5. PubMed ID: 12923971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective medical treatment of common baldness in women.
    Mortimer CH; Rushton H; James KC
    Clin Exp Dermatol; 1984 Jul; 9(4):342-50. PubMed ID: 6235065
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.
    Sahin Y; Bayram F; Keleştimur F; Müderris I
    J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of female pattern hair loss with oral antiandrogens.
    Sinclair R; Wewerinke M; Jolley D
    Br J Dermatol; 2005 Mar; 152(3):466-73. PubMed ID: 15787815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyproterone acetate on rate of hair growth in hirsute females.
    Jones KR; Katz M; Keyzer C; Gordon W
    Br J Dermatol; 1981 Dec; 105(6):685-92. PubMed ID: 6459114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyproterone acetate].
    Borelli C
    Hautarzt; 2002 Feb; 53(2):149. PubMed ID: 11963195
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
    Rautio K; Tapanainen JS; Ruokonen A; Morin-Papunen LC
    Eur J Endocrinol; 2005 Feb; 152(2):269-75. PubMed ID: 15745936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
    Karakurt F; Carlioglu A; Kaygusuz I; Gumus II; Uz B; Akdeniz D
    Arch Gynecol Obstet; 2014 Jan; 289(1):135-40. PubMed ID: 23880889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate].
    Audebert A; Emperaire JC; Gauthier A; Hallonet P; Hedon B; Lopes P; Quereux C; Roulier R
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):697-9. PubMed ID: 1838208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate-ethinyl estradiol treatment alters urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women.
    Luboshitzky R; Herer P; Shen-Orr Z
    Neuro Endocrinol Lett; 2002 Aug; 23(4):309-13. PubMed ID: 12195232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.
    Gruber DM; Sator MO; Joura EA; Kokoschka EM; Heinze G; Huber JC
    Arch Dermatol; 1998 Apr; 134(4):459-63. PubMed ID: 9554298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.